Hanna Sartor

14PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nutritional epidemiologyCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 18, 2026
Breast cancer and liver metastases: an imaging perspective on the potential of resectability.

Erik Baubeta, Hanna Valind, Oskar Hagberg

|Jul 11, 2024
Mammographic features differ with body composition in women with breast cancer.

Hanna Sartor, Li Sturesdotter, Anna-Maria Larsson

|May 02, 2023
Radiologically enlarged cardiophrenic lymph nodes and CA-125 in relation to diaphragmatic carcinomatosis, surgical outcome, and overall survival in advanced ovarian cancer.

Alba Plana, Robert Talo, Nils-Olof Wallengren

|Feb 23, 2023
Metabolic parameters of [18F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer.

Maria Markus, Hanna Sartor, Maria Bjurberg

|Apr 19, 2022
Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Nathalie Kliemann, Romain Ould Ammar, Carine Biessy

|Dec 30, 2020
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients.

Ida Skarping, Daniel Förnvik, Uffe Heide-Jørgensen

Pageof 3

Frequent Collaborators

4 joint publications

Sophia Zackrisson

3 joint publications

Elisabete Weiderpass

2 joint publications

Renée T Fortner

2 joint publications

Anne Tjønneland